Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an update.
ResMed Inc announced a change in beneficial ownership involving its Global General Counsel, Michael J. Rider, who acquired 2,941 shares of ResMed common stock. This acquisition was part of a performance-based restricted stock unit plan, highlighting the company’s commitment to aligning executive compensation with performance metrics, which could positively impact stakeholder confidence in the company’s governance practices.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$51.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc operates in the healthcare industry, focusing on the development and manufacturing of equipment related to sleep disorders, respiratory care, and connected health solutions. The company is known for its innovative products that enhance the quality of life for patients with sleep apnea and other chronic respiratory conditions.
Average Trading Volume: 890,958
Technical Sentiment Signal: Buy
Current Market Cap: A$64.61B
Find detailed analytics on RMD stock on TipRanks’ Stock Analysis page.